Drug makers & biotechDrug and biotech companies, with their PACs and trade groups. Pharmacies and distributors are under Other health companies.Business › Health
ELI Lilly and Co. lobbied on 8 issues. See lobbying
Audits and penalties
1 administrative fine, published by the FEC
Its wordsWhat does this committee say it is for?
No published list of positions
This committee’s site publishes no list of positions we could read, and we found no statement of why it exists. We do not write one for it.
Who it gives toWhich candidates and committees get its money?
Each part reads different filings, so counts and totals can differ.
Party support distribution$628.5K to 140 candidates
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
For candidates $628,500
Republican 53%
Democratic 34%
Support by the party of the candidate
Party of the candidate
Candidates
Direct
Independent
Amount
Share
Republican
72
$332,000
$0
$332,000
53%
Democratic
44
$216,500
$0
$216,500
34%
Other or unresolved
24
$80,000
$0
$80,000
13%
Shown support
140
$628,500
$0
$628,500
100%
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Who this PAC gave to$1,269,500 in 421 payments
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
By recipient
Line 23 contributions by kind and party of recipient
Recipient
Count
Amount
Democratic candidates
45
$221.5K · 17%
Republican candidates
71
$329.5K · 26%
Other or unresolved candidates
25
$82.5K · 6.5%
Democratic party committees
3
$50K · 3.9%
Republican party committees
4
$95K · 7.4%
Other party committees
1
$30K · 2.3%
Other PACs and committees
62
$469K · 37%
All recipients
211
$1.3M
By the candidate’s state
Contributions to candidates by the candidate’s state
State
Candidates
Amount
California
14
$71K
Indiana
11
$59K
North Carolina
9
$56K
Florida
11
$33.5K
Texas
9
$32K
Illinois
4
$27.5K
Pennsylvania
5
$27.5K
New Jersey
6
$25.5K
The largest 8 of 42 states.
Recipients 211
Show candidate activity and the money network
Candidate and election activity as the recipients filed it
Steve Scalise2 receipts, latest Feb 10, 2026Scalise for Congress · H0LA01087$10K
S. Brett Brett Guthrie2 receipts, latest Mar 11, 2025Guthrie for Congress · H8KY02031$10K
Scott Peters2 receipts, latest Feb 10, 2026Scott Peters for Congress · H2CA52089$10K
George J. Kelly Jr.2 receipts, latest Feb 24, 2026Mike Kelly for Congress · H0PA03271$10K
Thomas Cotton2 receipts, latest Feb 24, 2026Cotton for Senate, Inc. · S4AR00103$10K
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Committee money network
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees funding this one
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
Committees funding this one
Name
Amount
Mullin for AmericaSenate campaign committee · Connected to MULLIN VICTORY FUND · 1 payment
$5K
$5K from 1 committee, counting every itemized receipt this cycle.
Committees this one funds
Disbursements this committee itemized to another committee: candidate contributions, party transfers and payments alike, not contributions only.
Committees this one funds
Name
Amount
NRSCParty committee (qualified) · Connected to YOUNG VICTORY COMMITTEE · 2 payments
Where the money came from $2,294,054 reported receipts
Tap a row with to see who gave.
Itemized (over $200)Donors who have given more than $200 this cycle, so the FEC itemizes (names) them.$1,739,97276%
Largest donors
James C. Gilroy III20 contributions, latest Sep 30, 2026 · SR. VP-US MARKET ACCESS · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$9,548
Laura Demayo Steele18 contributions, latest Aug 31, 2026 · GROUP VICE PRESIDENT-US CARDIOMETABOLI · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$9,478
Derek L. Asay20 contributions, latest Sep 30, 2026 · SR. VICE PRESIDENT-GOVERNMENT STRATEGY · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$9,005
Karen Caraher Quirk19 contributions, latest Sep 30, 2026 · SVP DEPUTY GENERAL COUNSEL - CHIEF LI · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,981
Elizabeth Ann Van Sant Hoffman19 contributions, latest Sep 30, 2026 · SR. VP-PORTFOLIO MANAGEMENT AND CLINIC · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,979
Daniel Lee Vondielingen19 contributions, latest Sep 30, 2026 · SR. VP - GLOBAL PARENTERAL NETWORK EXP · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,953
Jirong Lu18 contributions, latest Sep 30, 2026 · SR. VICE PRESIDENT - BIOTECHNOLOGY RES · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,905
Janelle A. Pharm.D Sabo19 contributions, latest Sep 30, 2026 · SR. VICE PRESIDENT-CLINICAL CAPABILITI · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,873
Jack R. Goodpasture Jr.20 contributions, latest Sep 30, 2026 · SR. VICE PRESIDENT - GLOBAL MEDICAL AF · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,834
Prentice Curtis Stovall Jr. Jr.19 contributions, latest Sep 30, 2026 · SR. VICE PRESIDENT-STRATEGY & GLOBAL M · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,819
Andrea Abell17 contributions, latest Aug 31, 2026 · SR. VICE PRESIDENT - CHIEF INFORMATION · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,802
Stephanie Suzanne McCallum16 contributions, latest Aug 31, 2026 · GROUP VICE PRESIDENT - CHIEF ETHICS AN · ELI LILLY AND COMPANY · INDIANAPOLIS, IN$8,794
A donor who gave several times appears once. The 12 largest donors by total given are listed. In all, 13,442 itemized contributions were filed this cycle, totaling $1.7M. FEC contributor lists are public records and cannot be used for commercial solicitation.
Unitemized ($200 or less)Donors who have given $200 or less this cycle, so the FEC does not itemize (name) them.$525,66223%
Refunds and rebatesMoney coming back to the committee: rebates and refunds of what it spent, contributions it made that were returned, and loans it made that were repaid.$24,0001%
Other receiptsInterest, dividends and other income the committee files on a line of its own.$4,4190.2%
Where it came from
JP Morgan Chase1 receipt, latest Jul 31, 2025 · New York, New York$3,419
Walker for Indiana2 receipts, latest Jan 13, 2026 · Indianapolis, Indiana$1,000
The 2 largest sources are listed. Each as the committee named it on this line, $4.4K from 2 sources in all.
Total reported receipts $2,294,054
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. FEC filings through Oct 14, 2026.
Where the money traces to $2.3M followed back through up to 3 committees
18% to named individuals, 82% not itemized.
Gave directly$1.9M 82%
Gave directly
Name
Amount
Not itemized by this committee82%
$1,870,836
52 smaller sources, $423.2K in all (18%), are not listed.
Each committee that gave is followed to where its own money came from, in proportion to what it received: a committee that got half its money from one person is counted as passing half of what it gave on to that person. Each channel shows the committee the money came through and its place in the money tree. It shows who stood behind the money, not what that money was for, and an organization that need not name its donors ends the trail. It stops at a person, an organization, a committee with nothing on file here, or 3committees deep. A person who gave by more than one route appears under each, a name filed two ways may appear twice, and a person's job and city are as they filed them. "Also behind" counts the other groups, among those that moved $100,000 or more into races, in which $100,000 or more traces to the same person, other than those this money came through or went on to.
Who donated: where they live, their employers and jobs
Where the donors live $1,735,380 placed by state
Loading the map
Tap or hover over a state, or focus the map and use the arrow keys, to read its total. Ctrl or ⌘ and scroll to zoom.
under $69.4K
$69.4K+
$277.7K+
$624.7K+
$1.1M+
none
Top states
Top donor states
Name
Amount
Indiana13,447 contributions · 100%
$1,735,380
By the state each contributor wrote on the filing. The FEC aggregates every Schedule A line together, so one committee or organization transfer can account for a whole state. Contributors who have given $200 or less this cycle are not itemized and cannot be placed on a map. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total.
Donors’ employers as filed
Donors’ employers
Employer as filed
Amount
ELI Lilly And Company13,442 contributions · 100% of ranked
$1,735,329
A further $51 came from donors whose answer names no employer (blank), so it is not ranked. Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($525,662) are not itemized, so no employer or occupation is filed for them.
Donors’ occupations as filed
Donors’ occupations
Occupation as filed
Amount
SpendingWhere does the money go?
How the spending splits $2,602,124 reported
Tap a row with to see who was paid.
Contributions to candidates and other committeesMoney given to federal candidates, party committees and other PACs.$1,309,50050%
Future Forum PAC2 payments · latest Jun 1, 2026 · CONTRIBUTION$10,000
Lobo PAC2 payments · latest Mar 9, 2026 · CONTRIBUTION$10,000
Oorah! PAC2 payments · latest May 21, 2026 · CONTRIBUTION$10,000
Common Ground PAC2 payments · latest Feb 16, 2026 · CONTRIBUTION$10,000
Other disbursementsEverything the committee reports outside the lines above.$1,291,65050%
Paid to
Operating expendituresThe committee's own running costs.$865<0.1%
Paid to
Department of Treasury1 payment · latest Feb 18, 2026 · PAC TAXES - 35-1416962; FORM 1120POL - 2025 TAX PERIOD$697
Contribution refundsMoney returned to the people and committees that gave it.$110<0.1%
Total reported disbursements $2,602,124
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Oct 14, 2026.
What the payments were for $2,561,847 itemized
Tap a row with to see what was paid for.
Given to othersContributions to other candidates, party committees, and PACs.$1,874,35073%
Filed as
CONTRIBUTION$1,503,850
CONTRIBUTION TO 527 ORGANIZATION$335,000
CONTRIBUTION TO STATE PARTY ACCOUNT$11,500
CONTRIBUTION TO 527 POLITICAL ORGANIZATION$10,000
CONTRIBUTION TO SEGREGATED ACCOUNT$6,000
CONTRIBUTION - STATE ACCOUNT$5,000
CONTRIBUTION TO 501(C)(4)$3,000
Paid to
Democratic Governors Association$177,500
Republican Governors Association$162,500
National Republican Senatorial Committee$30,000
DSCC$30,000
National Republican Congressional Committee$30,000
$2.6M spent from Jan 2025 to Oct 2026. Most in one report: $486.9K, March 2026.
$2.6M
Jan 2025Oct 2026
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
Each report’s total
Oct 1 – Oct 14, 2026$49,250
September 2026$95,200
August 2026$110,900
July 2026$82,000
June 2026$82,500
May 2026$124,252
April 2026$63,550
March 2026$486,911
February 2026$337,115
January 2026$0
December 2025$30,763
November 2025$103,000
October 2025$98,506
September 2025$116,367
August 2025$103,610
July 2025$201,750
June 2025$88,700
May 2025$72,500
April 2025$67,500
March 2025$298,000
February 2025$0
January 2025$0
Show other payments: transfers, refunds and the rest
Published by the Commission against this committee’s own FEC ID. An audit is a periodic examination that reports findings; an administrative fine is a penalty for filing a specific report late or not at all. They are separate instruments and are not combined into a score here.
Source: the Commission’s audit-case and administrative-fine records, joined on this committee’s FEC ID, imported Nov 8, 2026. Enforcement matters (MURs) are published only against respondent names, with no committee identifier, so they are not shown here rather than being matched by name.
LobbyingWhat does its sponsor lobby on?
What ELI Lilly and Company lobbies on 2026 reports
Besides giving through its PAC, ELI Lilly and Company pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Spent on lobbying in 2026
$9.6M
Quarterly reports read
49
Bills it named
13
Topics it lobbied on
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
Health Issuesin 33 report entries · 6 bills named
In its own words
Patient protection;
Pharmaceutical supply chain issues and shortages;
Drug pricing, coverage, value, access and quality;
Transparency;
Intellectual property;
Health insurance accessibility;
Implementation of the "Inflation Reduction Act" (HR.5376);
Prescription drug approval;
Policy matters related to Artificial Intelligence in health care; clinical trial reforms;
FDA policy issues
Policy matters related to Artificial Intelligence in health care
Issues related to drug pricing;
Issues related to reimbursement of insulin products;
Issues related to the One Big Beautiful Bill Act (PL 119-21);
Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025;
Issues related to FDA guidance on Alcohol Use Disorder (AUD).
Issues related to insulin pricing;
Issues related to the pricing of GLP-1 therapeutic products;
Issues regarding the 340B Drug Pricing Program;
Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025;
Issues related to H.R. 6509 - SAFE Drugs Act of 2025;
Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Insulin pricing;
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies.
SAFE Drugs Act (HR6509/S3794).
FDA actions on drug compounding and illicit drugs.
Issues related to TrumpRX.
Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Medicare/Medicaidin 21 report entries · 9 bills named
In its own words
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease;
Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025;
Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025;
Issues related to H.R. 6509 - SAFE Drugs Act of 2025;
Issues related to S. 3794 - SAFE Drugs Act of 2026.
Intellectual property; 340B Program;
Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access;
Implementation of the "Inflation Reduction Act" (HR.5376);
CMS National Coverage Determination on Alzheimer's disease
Issues related to drug pricing and reimbursement for prescription drugs;
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169);
Issues related to the One Big Beautiful Bill Act (PL 119-21);
Issues related to S. 3267 - ASAP Act.
Issues related to drug pricing;
Issues related to reimbursement of insulin products;
H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Pharmacyin 19 report entries
In its own words
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.
Issues related to FDA regulation of pharmaceuticals.
Issues related to the 340B program.
Drug pricing, coverage, value, access and quality.
Prescription drug approval.
Drug importation. 340 B. Intellectual property.
Pharmaceutical supply chain issues and shortages.
Transparency.
Issues related to intellectual property protection and market access within current trade negotiations.
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act; clinical trial reforms; FDA policy issues
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act
Offices it contacted
SENATE
Trade (domestic/foreign)in 15 report entries
In its own words
Issues related to intellectual property protection and market access within current trade negotiations.
Canada IP;
USMCA implementation;
Mexico patent linkage;
Special 301;
Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil;
US Tariffs
Monitor Issues related to intellectual property protection and market access within current trade negotiations.
Section 232 investigations and other tariff issues.
Pharmaceutical IP issues, march-in rights.
Issues related to China WRT the BINSA bill.
Issues related to intellectual property protection, enforcement and market access issues within trade negotiations; supply chain management; issues related to China trade;
Issues related to global health; and issues related to tariffs.
Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights.
There is no specific bill filed. Engagement relates to issues on healthcare and trade.
Issues related to trade
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Health & Human Services, Dept of (HHS)
Treasury, Dept of
Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriationsin 9 report entries
In its own words
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (PL 119-21).
Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.
federal budget issues
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
Copyright/Patent/Trademarkin 6 report entries · 3 bills named
In its own words
Issues related to intellectual property;
Issues related to S. 1041 - Affordable Prescriptions for Patients Act;
Issues related to patent thickets;
Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act;
Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.
Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping
International and domestic tax issues. Implementation of PL 119-21.
Williams and Jensen, PLLCLobbying firm · 3 reports$150K
Venn StrategiesLobbying firm · 3 reports$140K
Monument AdvocacyLobbying firm · 3 reports$120K
B Hall Strategies, LLCLobbying firm · 3 reports$90K
The Harple Group, LLCLobbying firm · 3 reports$30K
Contributions on the LD-203 report
Reported twice a year by the lobbying filer. $233.4K is political giving that also appears in FEC filings.
Richard Neal$12K
Brian Fitzpatrick$10K
Charles Schumer$10K
Jason Smith$10K
Maggie Hassan$10K
Mike Thompson$10K
Roger Marshall$10K
Linda Sanchez$8K
Martin Heinrich$7K
Adrian Smith$6K
Matched by name: these reports are filed for “ELI LILLY AND COMPANY”, found by searching “ELI LILLY”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Nov 8, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
ELI Lilly and Co. PAC is registered with the Federal Election Commission as a PAC (qualified). It is a lobbyist/registrant PAC. Its FEC record names ELI Lilly and Co. as an affiliate. Official FEC summary: Federal Election Commission committee record.
Pages quoted 0 pages
No pages quoted
Nothing from this committee’s or its sponsor’s site is quoted yet.
Linked public records
No approved organization identity yet
The official FEC committee record remains available under Filings.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
Executive Vice President And President124 contributions · 4% of ranked
$44,680
Associate Vice President - Assistant G86 contributions · 1.7% of ranked
$19,099
Associate Vp-federal Government Affair44 contributions · 1.2% of ranked
$13,105
Vice President-global Regulatory Affai56 contributions · 1.1% of ranked
$12,400
SR Director - State Government Affair61 contributions · 1.1% of ranked
$11,723
SR Vice President-global Medical Affa32 contributions · 0.9% of ranked
$10,163
SR Vice President-research28 contributions · 0.9% of ranked
$9,879
SR Vice President-government Strategy21 contributions · 0.8% of ranked
$9,228
Ranked from the largest 200 of 201 occupation spellings filed; each share is of the money in those. Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($525,662) are not itemized, so no employer or occupation is filed for them.
Democratic Governors Association4 payments · latest Mar 30, 2026 · CONTRIBUTION TO 527 ORGANIZATION$177,500
Indiana Democratic State Central Committee3 payments · latest Sep 18, 2026 · CONTRIBUTION$15,000
Citizens for Destin Hall3 payments · latest Apr 13, 2026 · DESTIN HALL, STATE HOUSE 87TH NC$13,600
Pennsylvania House Democratic Campaign Committee4 payments · latest Feb 24, 2026 · CONTRIBUTION$13,500
OtherPayments whose filed description does not match any category above. Every one is listed so it can be read directly.
$683,30027%
Filed as
JOSH SHAPIRO, GOVERNOR PA$35,000
ALL PURPOSE - ERIC SWALWELL, GOVERNOR CA$25,000
GREG ABBOTT, GOVERNOR TX$25,000
TODD HUSTON, STATE HOUSE 37TH IN$15,000
DESTIN HALL, STATE HOUSE 87TH NC$13,600
DUSTIN BURROWS, STATE HOUSE 83RD TX$10,000
DAN PATRICK, LT. GOVERNOR TX$10,000
RODRIC BRAY, STATE SENATE 37TH IN$10,000
ALL PURPOSE - SION ROY, STATE SENATE 24TH CA$10,000
EMANUEL WELCH, STATE HOUSE 7TH IL$9,000
CHARLES SCHWERTNER, STATE SENATE 5TH TX$7,500
PHILIP BERGER, STATE SENATE 26TH NC$6,800
Paid to
Shapiro for Pennsylvania$35,000
Eric Swalwell for Governor 2026$25,000
Texans for Greg Abbott$25,000
Citizens for Destin Hall$13,600
Todd Huston for State Representative$10,000
Dustin Burrows Campaign$10,000
Office and administrativeRent, utilities, phones, supplies, equipment, security, food, and campaign merchandise.$3,0000.1%
Filed as
ALL PURPOSE - MONIQUE LIMON, STATE SENATE (OFFICE HOLDER ACCOUNT) 21ST CA$3,000
Paid to
Limon for Senate 2024 Officeholder Account$3,000
Taxes, fees, and bank chargesPayroll and income taxes, filing fees, bank and merchant processing charges.$697<0.1%
Filed as
PAC TAXES - 35-1416962; FORM 1120POL - 2025 TAX PERIOD$697
Paid to
Department of Treasury$697
Digital and technologyWebsites, hosting, software subscriptions, databases, email, and texting platforms.$500<0.1%
Filed as
SCOTT WEBSTER, STATE SENATE 47TH IA$500
Paid to
Webster for Iowa$500
Total itemized disbursements $2,561,847
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Oct 14, 2026.
All 1,209 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
Largest vendors
Largest vendors
Name
Amount
Democratic Governors Association4 payments · 6.8% of all spending
$177,500
Republican Governors Association3 payments · 6.2% of all spending
$162,500
Shapiro for Pennsylvania2 payments · 1.3% of all spending
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.
Democratic Governors Association4 payments, latest Mar 30, 2026CONTRIBUTION TO 527 ORGANIZATION$177.5K
Republican Governors Association3 payments, latest Mar 30, 2026CONTRIBUTION$162.5K
Eric Swalwell for Governor 20261 payment, latest Feb 16, 2026ALL PURPOSE - ERIC SWALWELL, GOVERNOR CA$25K
Texans for Greg Abbott1 payment, latest Oct 8, 2026GREG ABBOTT, GOVERNOR TX$25K
Transfers, refunds, and everything else the committee itemized outside candidate giving. 787 payments totaling $1.3M.
Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access. CMS National Coverage Determination on Alzheimer's disease. Implementation of the Inflation Reduction Act.